Nanobiotix S.A.

NASDAQ: NBTX · Real-Time Price · USD
8.14
-0.06 (-0.73%)
At close: Aug 15, 2025, 3:59 PM
8.26
1.47%
After-hours: Aug 15, 2025, 07:56 PM EDT

Nanobiotix S.A. Income Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
-11.61M 36.21M 4.78M 10K
Cost of Revenue
n/a n/a 985K n/a
Gross Profit
-11.61M 36.21M 3.79M 10K
Operating Income
-68.39M -26.78M -46.7M -52.58M
Interest Income
2.63M 1.22M 256K 6.17M
Pretax Income
-68.03M -39.58M -57.03M -47M
Net Income
-68.13M -39.7M -57.04M -47M
Selling & General & Admin
20.06M 22.05M 17.48M 19.43M
Research & Development
40.54M 38.4M 32.64M 30.38M
Other Expenses
-3.82M 2.54M -3.41M -2.64M
Operating Expenses
56.78M 62.99M 46.7M 47.17M
Interest Expense
8.09M 7.98M 5.84M 590K
Selling & Marketing Expenses
n/a 388K n/a n/a
Cost & Expenses
56.78M 62.99M 46.7M 47.17M
Income Tax Expense
101K 120K 10K 5K
Shares Outstanding (Basic)
47.27M 36.76M 34.85M 34.73M
Shares Outstanding (Diluted)
47.27M 36.93M 34.85M 34.73M
EPS (Basic)
-1.44 -1.08 -1.64 -1.35
EPS (Diluted)
-1.44 -1.08 -1.64 -1.35
EBITDA
-58.32M -23.69M -45.15M -45.6M
EBIT
-59.95M -24.24M -45.72M -46.33M
Depreciation & Amortization
1.62M 551K 1.5M 1.56M